8-K: Current report filing
Published on January 8, 2009
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 5,
2008
|
CryoPort,
Inc.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Nevada
|
000-51578
|
88-0313393
|
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
20382
Barents Sea Circle, Lake Forest, California
|
92630
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (949)
470-2300
|
Not
Applicable
|
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 1 4a- 12 under the Exchange Act (17 CFR
240.1 4a- 12)
[ ]
Pre-commencement communications pursuant to Rule 1 4d-2(b) under the Exchange
Act (17 CFR 240.1 4d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 1 3e-4(c) under the Exchange
Act (17 CFR 240.1 3e-4(c))
Item
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On
December 5, 2008 the Company’s Board of Directors appointed Larry G. Stambaugh
to fill the vacancy left by Stephen Scott’s resignation in November 2008. The
Company Board then unanimously elected Mr. Stambaugh to the position of
Chairman.
Mr.
Stambaugh is currently a Principal of Apercu Consulting and sits on the boards
of several companies, including EcoDog, Ridge Diagnostics, and
BioCom. He is also currently on the Board of Directors of the
Corporate Directors Forum. At Apercu, Mr. Stambaugh serves as an advisor to
several private and public boards and CEOs, concentrating on strategic business
direction, turnarounds and board governance. Mr. Stambaugh brings to
Cryoport more than 30 years of successful experience building global businesses
and setting strategies. He also brings an extensive background in life sciences
and clean tech including relationships with and knowledge of Contract Research
Organizations and biotech and pharmaceutical companies. Mr. Stambaugh
earned his BBA Accounting/Finance from Washburn University in 1969.
Attached is the CryoPort, Inc. Board of
Directors Agreement between the Company and Larry G. Stambaugh memorializing the
terms of Mr. Stambaugh’s compensation for serving as a director and Chairman of
the Company Board.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits
10.15 CryoPort, Inc. Board
of Directors Agreement, dated December 10, 2008.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
CryoPort,
Inc.
|
|
|
(Registrant)
|
|
|
Date:
January 8, 2009
|
By: /s/ Peter
Berry
|
|
Peter
Berry,
|
|
|
Chief
Executive Officer, President
|